|
Oncogenes and Tumor Suppressors
Citations 111-120 of 795 total displayed.
|
Past content
(since May 2000):
|
Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis
- Guang Jin, Yukari Yamazaki, Miki Takuwa, Tomoko Takahara, Keiko Kaneko, Takeshi Kuwata, Satoshi Miyata, and Takuro Nakamura
Blood 2007; 109: 3998-4005.
[Abstract]
[Full text]
[PDF]
MEK1/2 inhibitors sensitize Bcr/Abl+ human leukemia cells to the dual Abl/Src inhibitor BMS-354/825
- Tri K. Nguyen, Mohamed Rahmani, Hisashi Harada, Paul Dent, and Steven Grant
Blood 2007; 109: 4006-4015.
[Abstract]
[Full text]
[PDF]
Tumor suppressor PTEN is a physiologic suppressor of chemoattractant-mediated neutrophil functions
- Kulandayan K. Subramanian, Yonghui Jia, Daocheng Zhu, Benjamin T. Simms, Hakryul Jo, Hidenori Hattori, Jian You, Joseph P. Mizgerd, and Hongbo R. Luo
Blood 2007; 109: 4028-4037.
[Abstract]
[Full text]
[PDF]
Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis
- Jorge Cortes, Philippe Rousselot, Dong-Wook Kim, Ellen Ritchie, Nelson Hamerschlak, Steven Coutre, Andreas Hochhaus, Francois Guilhot, Giuseppe Saglio, Jane Apperley, Oliver Ottmann, Neil Shah, Philipp Erben, Susan Branford, Prasheen Agarwal, Ashwin Gollerkeri, and Michele Baccarani
Blood 2007; 109: 3207-3213.
[Abstract]
[Full text]
[PDF]
ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia
- Deepa B. Shankar, Junling Li, Paul Tapang, J. Owen McCall, Lori J. Pease, Yujia Dai, Ru-Qi Wei, Daniel H. Albert, Jennifer J. Bouska, Donald J. Osterling, Jun Guo, Patrick A. Marcotte, Eric F. Johnson, Niru Soni, Kresna Hartandi, Michael R. Michaelides, Steven K. Davidsen, Saul J. Priceman, Jenny C. Chang, Katrin Rhodes, Neil Shah, Theodore B. Moore, Kathleen M. Sakamoto, and Keith B. Glaser
Blood 2007; 109: 3400-3408.
[Abstract]
[Full text]
[PDF]
A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5
- Marina Bousquet, Cyril Broccardo, Cathy Quelen, Fabienne Meggetto, Emilienne Kuhlein, Georges Delsol, Nicole Dastugue, and Pierre Brousset
Blood 2007; 109: 3417-3423.
[Abstract]
[Full text]
[PDF]
CBFB-MYH11 hinders early T-cell development and induces massive cell death in the thymus
- Ling Zhao, Jennifer L. Cannons, Stacie Anderson, Martha Kirby, Liping Xu, Lucio H. Castilla, Pamela L. Schwartzberg, Rémy Bosselut, and P. Paul Liu
Blood 2007; 109: 3432-3440.
[Abstract]
[Full text]
[PDF]
Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo
- Guang-Biao Zhou, Hui Kang, Lan Wang, Li Gao, Ping Liu, Jun Xie, Feng-Xiang Zhang, Xiang-Qin Weng, Zhi-Xiang Shen, Jue Chen, Long-Jun Gu, Ming Yan, Dong-Er Zhang, Sai-Juan Chen, Zhen-Yi Wang, and Zhu Chen
Blood 2007; 109: 3441-3450.
[Abstract]
[Full text]
[PDF]
Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia
- José Román-Gómez, Lucia Cordeu, Xabier Agirre, Antonio Jiménez-Velasco, Edurne San José-Eneriz, Leire Garate, María José Calasanz, Anabel Heiniger, Antonio Torres, and Felipe Prosper
Blood 2007; 109: 3462-3469.
[Abstract]
[Full text]
[PDF]
Activation of a novel Bcr/Abl destruction pathway by WP1130 induces apoptosis of chronic myelogenous leukemia cells
- Geoffrey A. Bartholomeusz, Moshe Talpaz, Vaibhav Kapuria, Ling Yuan Kong, Shimei Wang, Zeev Estrov, Waldemar Priebe, Ji Wu, and Nicholas J. Donato
Blood 2007; 109: 3470-3478.
[Abstract]
[Full text]
[PDF]
|
|
